Patents Examined by Anish Gupna
  • Patent number: 5965520
    Abstract: Disclosed is a therapeutic regime for treating patients with rheumatoid arthritis (RA) Supplemental growth hormone is periodically administered to raise insulin-like growth factor 1 (IGF-1) levels, and the IGF-1 levels are monitored until they reach optimal levels and RA symptoms subside.
    Type: Grant
    Filed: July 25, 1996
    Date of Patent: October 12, 1999
    Assignee: Research Corporation Technologies
    Inventor: Robert M. Bennett